Research Funding Archive
Research Funding RSS
The Research Funding section of this website lists specific research opportunities relevant to nanotechnology and cancer. Training and fellowship funding opportunities are listed in the Training section of the Alliance website. Also visit the NIH Guide for Grants and Contracts for the latest publication of all NIH funding opportunities and notices.
Provocative Questions: |
Complete list of the NCI's new round of Provocative Questions Group A generally relates to cancer prevention and risk. Research Answers to NCI's Provocative Questions- Group A (R01) Research Answers to NCI's Provocative Questions- Group A (R21) Group B generally relates to mechanisms of tumor development or recurrence. Research Answers to NCI's Provocative Questions- Group B (R01) Research Answers to NCI's Provocative Questions- Group B (R21) Group C generally relates to cancer detection, diagnosis, and prognosis. Research Answers to NCI's Provocative Questions- Group C (R01) Research Answers to NCI's Provocative Questions- Group C (R21) Group D generally relates to cancer therapy and outcomes. Research Answers to NCI's Provocative Questions- Group D (R01) Research Answers to NCI's Provocative Questions- Group D (R21) |
RFAs: |
Early-Stage Innovative Molecular Analysis Technology Development for Cancer Research (R21) Validation and Advanced Development of Emerging Molecular Analysis Technologies for Cancer Research (R33) Early-Stage Development of Innovative Technologies for Biospecimen Science (R21) Validation and Advanced Development of Emerging Technologies for Biospecimen Science (R33) SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization (R44) |
PAs: |
PHS 2013-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Years 2013 and 2014 (P50) Exploratory/Developmental Bioengineering Research Grants (EBRG) [R21] Biomarkers for Early Detection of Hematopoietic Malignancies (R21) Biomarkers for Early Detection of Hematopoietic Malignancies (R01) Identifying Non-coding RNA Targets for Early Detection of Cancer (R01) Identifying Non-coding RNA Targets for Early Detection of Cancer (R21) Translational Research at the Aging/Cancer Interface (TRACI) (R01) Translational Research at the Aging/Cancer Interface (TRACI) (R21) Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R21) Bioengineering Research Partnerships (R01) Biotechnology, Biochemical, and Biomass Engineering Biomedical Engineering Nanoscience and Nanotechnology in Biology and Medicine (R01) Nanoscience and Nanotechnology in Biology and Medicine (R21) Cancer Diagnostic and Therapeutic Agents Enabled by Nanotechnology [SBIR (U43/U44)] Image Guided Drug Delivery in Cancer (R01) Academic-Industrial Partnerships for Translation of in vivo Imaging Systems for Cancer Investigations (R01) Image-Guided Cancer Interventions (SBIR R43/R44) Image-Guided Cancer Interventions (STTR R41/R42) Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01) NIH Pathway to Independence Award (K99/R00) Mentored Quantitative Research Development Award (K25) Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research Feasibility Studies for Collaborative Interaction for Minority Institution/Cancer Center Partnership PHS 2013-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications Bioengineering Research Grants (BRG) (R01) Biomechanics and Mechanobiology Technology Development for the Detection and Evaluation of Chemical and Biological Carcinogens (SBIR) [R43/R44] Technologies and Software to Support Integrative Cancer Biology Research (SBIR) [R43/R44] Technology for the Detection and Characterization of Low Abundance Proteins, Peptides, or micro RNAs (SBIR) [R43/R44] |
